ReviewFrontiers in cardiovascular medicine2026
Transcriptional regulation in cardiovascular aging.
Review in Frontiers in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cardiovascular diseases (CVD) stand as the primary cause of mortality and form the most prevalent disease category. Numerous studies have demonstrated that aging serves as a crucial pathogenic factor in the progression of CVD. Nevertheless, the molecular mechanisms underlying cardiovascular aging have not been fully elucidated. Research in various aging models has consistently shown that aging is attributed to the dysfunction of a complex transcriptional regulatory network that maintains the body's health, tissue homeostasis, and stress resistance. Transcription factors and chromatin regulatory factors are involved in almost all cellular activities, and an increasing amount of evidence indicates that as key regulatory elements, transcription factors and chromatin regulators control cellular senescence by regulating the transcription of related genes. Therefore, the aim of this review is to summarize the specific role of transcriptional regulation in the mechanism of cardiovascular aging, providing new strategies for the treatment of CVD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.